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Evaluation of the Olympus AU-510 analyser
Carmen Farr, Jestls Velasco and Francisco Ram6n
Servei de Bioquimica, Hospital SantJoan de Deu, Carretera d’Esplugas, s/n 08034
Barcelona, Spain
The selective multitest Olympus A U-510 analyser was evaluated
according to the recommendations of the Comision de Instrumenta-
cion de la SociedadEspaola de Quimica Clinica and the European
Committeefor Clinical Laboratory Standards. The evaluation was
carried out in two stages: an examination of the analytical units
and then an evaluation in routine work conditions. The operational
characteristics of the system were also studied.
The first stage included a photometric study: dependent on the
absorbance, the inaccuracy varies between +0"5% to -0"6% at
405 nm andfrom -5"6% to 10"6% at 340 nm; the imprecision
ranges between -0"22% and 0"56% at 405 nm and between
0"09% and 2"74% at 340 nm. Linearity was acceptable, apart
from a very low absorbance for NADH at 340 nm; and the
imprecision of the serum sample pipetter was satisfactory.
Twelve serum analytes were studied under routine conditions:
glucose, urea urate, cholesterol, triglycerides, total bilirubin,
creatinine, phosphate, iron, aspartate aminotransferase, alanine
aminotransferase and gamma-glutamyl transferase.
The within-run imprecision (CV%) ranged from 0"67% for
phosphate to 2"89% for iron and the between-run imprecisionfrom
0"97% for total bilirubin to 7"06% for iron. There was no carry-
over in a study ofthe serum samplepipetter. Carry-over studies with
the reagent and sample pipetters shows some cross contamination in
the iron assay.
Materials and methods
Instrument
The Olympus AU-510 (manufactured by Olympus
Optical and distributed by Merck-Igoda S.A.) is a
discrete, selective and multitest analyser. The analyser
and the data processor are two separate units, with a hard
disc of 20 Mb in the latter. The Olympus can hold up to
99 different tests and can be programmed to make 33
simultaneous tests on each sample. It can store results for
up to 4000 patients, with a maximum of 60 analytes for
each patient.
The results obtained cannot be compared with other
instruments because the methodologies used vary and
because the system is an open one.
The samples, held in a chain, can be introduced to the
instrument in a primary tube or in a variety ofsecondary
tubes; 100 samples can be run and more samples may be
added at any time. The identification ofthe serum may be
sequential or by bar code. The photometric unit has a
diffraction-grating photometer and 10 differential filters.
In a rotor with 90 positions for cuvettes, the photometric
measurements are made every 9 s. The cuvettes are used
once only and the volume of the sample varies between 3
and 50 1 the reagent volume varies between 20 and
300 ,1. The total volume of each cuvette is between 265
and 1150 ,1.
Introduction
The Olympus AU-510 is a selective multichannel ana-
lyser for both routine and urgent analyses in medium to
large laboratories. The present evaluation was carried
out in accordance with the protocol of the Comision de
Instrumentacion de las Sociedad Espafiola de Quimica
Clinica (SEQC) [1] and the guidelines of the European
Committee for Clinical Laboratory Standards (ECCLS)
[2].
The evaluation of the analytical units included a study of
inaccuracy, within- and between-run imprecision, and
photometric linearity from 340 to 410 nm, as well as the
imprecision of serum sample pipetter.
The within- and between-run imprecision was studied for
12 serum analytes under routine conditions; carry-over in
the serum and reagent sample pipetters was also
examined.
The analyser contains a freezer where the reagents are
held between 4C and 10C in 18 ml aliquots. Every test
has up to nine positions for reagents which may or not be
concentrated; three sets of40 positions may be defined for
reagent I (R-I) and three sets of 16 positions for reagent
II (R-II).
Reagents
Non-standard abbreviations are used here: M, Merck; S,
Sigma; AST, aspartate aminotransferase (E.C. 2.6.1.1);
ALT, alanine aminotransferase (E.C. 2.6.1.2); GGTP, y-
glutamyl transferase (E.C. 2.3.2.2); PNP, p-nitrophenol;
NADH, [3-nicotinamide adenine dinucleotide reduced
form; NaOH, sodium hydroxide.
The following solutions were used to test the analytical
units: PNP (Hopkin & Williams, 623800, Eurocontrol);
NaOH (M,6498); from a solution of360 tmol/1 ofPNP in
20mmol/1 of NaOH, different concentrations were
obtained by dilution; disodium salt ofNADH (S,N8129);
Tris(hidroxymethyl)methylamine (M,8387); from a solu-
tion of 300 lxmol/1 of NADH in 80 mmol/1 of Tris,
different concentrations were obtained by dilution.
In a practicability study, the versatility of the analyser,
flexibility of the software, treatment ofsamples, technical
training and preventative maintenance were evaluated.
For tests on samples of sera the following reagent tests
packs were used: glucose (M,14365M) (GOD-PAP); urea
(M,19702) (urase/GIDH); urate (M,19739) (uricase-
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Table 1. Photometric inaccuracy.
Mean
Theoretical observed Inaccuracy
absorbance absorbance* (%)
NADH 340 nm
PNP 410 nm
0"342 0"321 -6.73
0"685 0.648 -5.64
1"027 0.941 -9’21
1"370 1’270 -7"88
1"712 1.547 -10.67
0.610 0"613 +0.51
1"220 1"218 -0.19
1.830 1.793 -2.10
2"440 2"302 -6.00
* Triplicate measurements.
PAP); cholesterol (M,19738) (CHOD-PAP); tri-
glycerides (M,19706) (GPO-PAP); total bilirubin
(M,19717) (DPD); creatinine(M,19726) (Jaffa, without
deproteinization); phosphate (M,19723) (phospho-
molybdate reduction without deproteinization); iron
(M,19725) (ferrozine); AST (M,19708) (IFCC modi-
fied); ALT (M,19709) (IFCC modified); GGTP
(M, 19710) (y-glutamyl-3-carboxy-4-nitroanilide).
For the calibration the following were used: Calibrator
(M,19720) and for control sera: Qualitrol L (M,11307);
Qualitrol N (M,11305) and Qualitrol H (M,11306).
Parameters evaluated
Photometric inaccuracy
This is important when using a multiplying factor
obtained from the molar absorptivity coefficient (e).
Beginning with a solution ofPNP (144 mol/1) in NaOH
(20 mmol/1) for the study at 410 nm, and a solution of
disodium NADH (300 mol/1) in Tris buffer (80 mmol/1)
for the study of 340 nm, suitable dilutions and triplicate
readings were made. Theoretical absorbance according
to the molar absorptivity coefficient and the absorbance
obtained were compared. The results were expressed as
percentage according to the formula [(Vt-Vo)/Vo] x 100.
The Varian Cary-210 was used as a spectrophotometer of
known inaccuracy (see table 1).
Photometric imprecision
The same solutions were used as in the previous section
and the necessary dilutions were made to obtain approxi-
mate absorbances of 0"050, 0"100, 0"200, 0"500, 1"000,
and 2"000; 30 readings in the same run were made ofeach
dilution. The mean, standard deviation and coefficient of
variation for each of the wavelengths (340 and 410 nm)
were calculated (see table 2).
Photometric linearity
Triplicate measurements were made from an initial
solution of 2"000 units of absorbance down to 0"000 with
NADH at 340 nm and PNP at 410 nm. The percentage
difference between the theoretical value and the value
obtained for each of the dilutions was obtained. The
dilutions were produced manually off-line and the
analyses were realized in the same run (see tables 3 and
4).
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Table 2. Photometric imprecision.
Mean absor-
bance CV (%)
NADH 340 nm
PNP 410 nm
’641 0’ 11
0’888 0" 10
0"472 0"09
0"200 0"11
0"114 0’36
0’057 2’74
1"845 0"26
0"943 0’36
0"510 0’31
0"206 0"22
0"117 0"56
0’061 0"45
* N 30, within run.
Table 3. Photometric linearityfor NADH (340 nm).
Theoretical Mean observed Dispersion
absorbance absorbance* (%)
1"712 1"515 -11’5
1"541 1"439 -6"6
1"370 1’260 -8"0
1’199 1"125 -6’1
1’024 0’950 -7’5
0’856 0’819 -4"3
0"685 0’642 -6"3
0’514 0"497 -3’1
0"342 0’334 -2’4
0"171 0’176 +2’9
0"085 0’096 + 12"
0"040 0’051 + 28"6
* Triplicate measurements.
Table 4. Photometric linearityfor PNP (410 nm).
Theoretical Mean observed Dispersion
absorbance absorbance* (%)
2’026 1’930 -4"71
1’823 1’792 -1’72
1"621 1’561 -3"68
1"418 1"405 -0"90
1"216 1"182 -2’76
1"013 1"023 + 1"04
0"810 0’801 -1"18
0"608 0’618 + 1.76
0"405 0"403 -0"52
0"203 0"201 -0"99
0"101 0"107 +5’72
0"051 0"055 +9’09
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Table 5. Imprecision of the sample pipette delivery system (N
o).
Reagent
Sample pipette pipette
([al PNP) (B1 NaOH) CV (%)
3 250 1.78
18 250 0.75
27 250 0.98
33 250 0.89
48 250 1.14
Sample pipette delivery system imprecision
The following volumes were studied, based on the
maximum and minimum volumes recommended by the
manufacturer: rain, (2 min + max)/3, min + max/2,
(min + 2 max)/3, max. The sample was PNP at 3, 18, 27,
33 and 48 btl with a constant amount of 250 btl ofNaOH
(20 mmol/1). The PNP concentration was calculated in
each case so that the final absorbance was approximately
0’500.
For the evaluation of performance under routine work
conditions, the following parameters were studied (see
table 5).
Imprecision
Within the same run, 30 samples of control sera were
analysed at three levels, in order to obtain the within-run
imprecision. The same control sera were analysed for 30
days, once per day, at three levels and were used to obtain
the between-run imprecision.
Sample-related carry-over
In order to investigate the possible contamination
between two consecutive sera through the serum sample
pipetter, three high concentration sera were analysed:
H1, H2 and H3, followed by three sera of low concen-
trations (L1, L2 and L3), 10 times for each analyte. The
average value of (LI-L3) was calculated and its differ-
ence, h L l-L3, needed to be less than 2SD of the
within-run imprecision of that analyte.
Specimen-independent carry-over
To investigate the contamination through the reagent-
reagent pipetter, it was necessary to study all the possible
sequences of pipetting for the different reagents. The
model used was: IfA is the reagent studied and the rest
are B, C, D,..., the following sequence should be
constructed: A,A,A,B,A*,C,A*,D,A* etc. The carry-over
effect has to be less than 2SD of the within-run
imprecision per A*.
The results of this evaluation were:
Imprecision
The within- and between-run imprecision is summarized
in table 6 and is acceptable for all the analytes studied;
the lowest values are found for total bilirubin, phosphate
and GGTP, and the highest for iron and creatinine. These
analytes display very small changes of absorbance near
the concentration ofthe calibrator which means that they
have a poor reproducibility compared to the rest of the
analytes evaluated.
Sample-related carry-over
In table 7 no contamination shows via the sample arm in
the analytes studied. The difference between the concen-
tration of the supposedly contaminated sample L1 and
the non-contaminated L3 is practically nil for all the
analytes.
Specimen-independent carry-over
All the pipetting sequences of the reagents studied show
that there was no contamination between the different
reagents, except in the case of the iron, which, when
placed in front of the total proteins reagents, displays
contamination (>2SD of the within-run imprecision).
Practicability
This instrument is open for programming for different
analytical techniques. It can carry out enzyme activities,
kinetic or end-point determinations or methods with start
reagents. It has an option for seven different models of
mathematical calculation and accepts up to seven
calibrators per technique. The reaction can be con-
tinuously monitored.
Preferential or urgent samples may be processed at all
times through the STAT rotor which has eight positions.
The first result of a preferential sample is obtained
between 10"4 and 15 min after sampling.
Noteworthy features of the computer software are: the
repetition program which allows any analyte to be
repeated at any time and an ability to change the sample
volume; the diagnostic program which checks the
mechanical, electronic or optical performance of the
instrument; the data-processing program which allows
the demographic study ofpopulations, correlation studies
between analytes with presentation via graphics or
histograms, printing of different lists, etc.; a program of
quality control which defines up to 12 serum controls and
allows a maximum of six controls per analyte. The
instrument also permits storage ofup to 60 days ofquality
control results and works with both prefixed limits and
calculated values with visualisation of the results with
Levy-Jennings or Youden graphics.
The analyser connected on-line through an RS-232
interface.
For technical staff training, one week is enough to learn
the systematic work routine. For a deeper knowledge of
the system, and for learning how to program it, one
month should be sufficient.
The possibility of working with primary tubes avoids
manipulation of the sample. On the other hand, one has
to guard against the possible evaporation ofserum when
working with very small volumes in small wells for
paediatric samples, given that the samples are placed in
the analyser without caps. The process of sampling by
chain means that small dilutions may be obtained
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Table 6. Within- and between-run imprecisionfor concentrations and enzyme activities.
Within-run (N 30)
Mean SD CV (%)
Between-run (N 30)
Mean SD CV (%)
H 11.82 0"11 0"93
Glucose M 4"79 0"05 1.04
(mmol. l-l) L 2"33 0.04 1.71
H 34"42 0"49 "42
Urea M 7"08 0"09 1"27
(mmol. 1-1) L 2"53 0"03 1" 18
H 625"9 4"6 0"74
Urate M 377"9 4"9 1"30
(tmol. 1-1) L 200"3 2"5 1"24
H 6"30 0"05 0"80
Cholesterol M 2"55 0"02 "04
(mmol. 1-1) L 3"09 0"06 "94
H 2"78 0"03 1"08
Triglyceride M 1" 11 0"01 0"90
(mmol. 1-1) L 0"96 0"02 2"08
H 70"57 0"53 0-75
T. Bilirubin M 33"45 0"27 0"81
([mol. 1-1 L 23"60 0" 17 0"72
H 565"5 4"8 0"84
Creatinine M 184"5 2"6 "41
(tmol. 1-1 L 113"5 2"9 2"55
H 2"66 0"02 0"75
Phosphate M 1.35 0.01 0-74
(mmol. 1-1) L 1"33 0"01 0"75
H 34"87 0"62 1"77
Iron M 27" 16 0"28 1"03
(tmol. 1-1 L 15"81 0"46 2"91
H 206"8 0"62 1"77
AST M 120"4 0"99 0"83
(UI. 1-1) L 44"3 0"80 1"81
H 161"9 1"52 0"94
ALT M 78"0 0"68 0"87
(UI. 1-1) L 33.3 0.93 2.97
H 131.0 1.03 0.78
GGTP M 54.6 0.58 1.06
(UI. 1-1) L 24.1 0.31 1.28
10.80 0.13 1.25
4.81 0.08 1.65
2.23 0.04 1.77
27.60 0.47 1.69
6.90 0.09 1.29
2.60 0.04 1.54
606.2 9.1 1.50
360.6 8.3 2.30
198.9 3.7 1.86
6.13 0.10 1.59
2.34 0.06 2.37
3-08 0-05 1-69
2.69 0.06 2.12
1.12 0.04 3.17
0.98 0.02 2.05
68.66 0.66 0.97
32.13 0.51 1.58
22.90 0.38 1.66
637.0 16.02 2.51
187.9 4.84 2.57
113.4 3.25 2.86
2.70 0.05 1.86
1.37 0.03 2.24
1.32 0.03 2.02
32.93 0.01 3.05
26.63 0.89 3.36
16.24 1.15 7.06
204.8 3.9 1.92
114.8 3.2 2.82
44.8 1.3 2.95
169.1 4.5 2.69
80.1 2.5 3.14
35.3 1.4 4.02
133.1 2.6 1.95
55.5 1.2 2.10
24.5 0.8 3.20
Table 7. Sample related carry-over.
Concentration High h L1-L3
Glucose (mmol. 1-1) 10"9/2"33 0
Urea (mmol. l-l) 28" 1/2"61 0"04
Urate (mmol. 1-1) 606/215 0
Cholest. (mmol. 1-1) 6.0/3"03 0"01
Triglycer. (mmol. 1-1) 2"86/1"06 0
Total Bil. (mmol. 1-1) 76"9/25" 0
Creatinine (tmol. 1-1) 628/109 0
Phosphate (mmol. 1-1) 2"60/1"28 0
Iron (tmol. 1-1 32"4/15" 0
AST (U1.1-1) 225/44
ALT (U1. 1-1) 170/42 0
GGPT (U1.1-1) 132/24 0
Contamination was not found if ’h’ is less than 2 SD of the
within run imprecision.
through the program of repetitions, while large dilutions
have to be made manually.
The daily, weekly and monthly maintenance carried out
by the user is minimal but it is important to the efficient
functioning of the equipment. The quality of the water
used has to be optimal, particularly when working with
concentrated reagents.
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